These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 19377492

  • 1. Angina: Ivabradine for treatment of stable angina pectoris.
    de Silva R, Fox KM.
    Nat Rev Cardiol; 2009 May; 6(5):329-30. PubMed ID: 19377492
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
    Tardif JC, Ponikowski P, Kahan T, ASSOCIATE Study Investigators.
    Eur Heart J; 2009 Mar; 30(5):540-8. PubMed ID: 19136486
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Comparative efficacy of ivabradine and atenolol in correction of clinical and functional parameters in patients with stable effort angina].
    Tatarchenko IP, Pozdniakova NV, Biriuchenko MV.
    Kardiologiia; 2008 Mar; 48(5):60-1. PubMed ID: 18537806
    [No Abstract] [Full Text] [Related]

  • 5. [Stable angina pectoris. Effective symptom control and cardioprotection with ivabradine].
    MMW Fortschr Med; 2010 May 27; 152(21):102-3. PubMed ID: 20608138
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice.
    Koester R, Kaehler J, Ebelt H, Soeffker G, Werdan K, Meinertz T.
    Clin Res Cardiol; 2010 Oct 27; 99(10):665-72. PubMed ID: 20454968
    [Abstract] [Full Text] [Related]

  • 9. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A, Tardif JC.
    Adv Cardiol; 2006 Oct 27; 43():65-78. PubMed ID: 16936473
    [Abstract] [Full Text] [Related]

  • 10. Comparison of ivabradine plus beta-blockers versus beta -blocker therapy only.
    Aalbers J.
    Cardiovasc J Afr; 2010 Oct 27; 21(2):116. PubMed ID: 20532439
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
    Borer JS, Tardif JC.
    Am J Cardiol; 2010 Jan 01; 105(1):29-35. PubMed ID: 20102886
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.